Home
>
Inhibitors/Agonists>APIs>Anti-infection>Anti-virals>Bioactive Chemicals>Influenza Virus>
>
Baloxavir marboxil
For research use only. Not for therapeutic Use.
Baloxavir marboxil(Cat No.:I003941)is an antiviral medication used to treat acute, uncomplicated influenza in patients 12 years and older. It works by inhibiting the cap-dependent endonuclease enzyme, which is essential for viral replication. By blocking this enzyme, Baloxavir marboxil prevents the flu virus from multiplying, reducing the duration and severity of symptoms. Administered as a single-dose oral treatment, it offers a convenient and effective option, particularly when taken within 48 hours of symptom onset. Its novel mechanism makes it a key tool in fighting influenza, especially in cases resistant to other antivirals.
Catalog Number | I003941 |
CAS Number | 1985606-14-1 |
Synonyms | Baloxavir marboxil;({(12aR)-12-[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-6,8-dioxo-3,4,6,8,12,12ahexahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazin-7-yl}oxy)methyl methyl carbonate |
Molecular Formula | C27H23F2N3O7S |
Purity | 97% |
Target | Influ PA |
Target Protein | P03433 |
Solubility | Soluble in DMSO |
Appearance | Solid |
Storage | Dry, dark and at 2 - 8 °C for six months or -20°C for two years. |
IUPAC Name | [(3R)-2-[(11S)-7,8-difluoro-6,11-dihydrobenzo[c][1]benzothiepin-11-yl]-9,12-dioxo-5-oxa-1,2,8-triazatricyclo[8.4.0.03,8]tetradeca-10,13-dien-11-yl]oxymethyl methyl carbonate |
InChI | InChI=1S/C27H23F2N3O7S/c1-36-27(35)39-14-38-25-19(33)8-9-31-24(25)26(34)30-10-11-37-12-21(30)32(31)23-15-6-7-18(28)22(29)17(15)13-40-20-5-3-2-4-16(20)23/h2-9,21,23H,10-14H2,1H3/t21-,23+/m1/s1 |
InChIKey | RZVPBGBYGMDSBG-GGAORHGYSA-N |
SMILES | COC(=O)OCOC1=C2C(=O)N3CCOC[C@H]3N(N2C=CC1=O)[C@H]4C5=C(CSC6=CC=CC=C46)C(=C(C=C5)F)F |